Literature DB >> 34016569

Impact of obesity and diabetes mellitus in critically ill patients with SARS-CoV-2.

Elizabeth Pérez-Cruz1, Jorge Alberto Castañón-González2, Salvador Ortiz-Gutiérrez3, Jessica Garduño-López2, Yuritzy Luna-Camacho3.   

Abstract

PURPOSE: Evaluate the associations of obesity and diabetes with the risk of mortality in critically ill patients infected with SARS-CoV-2.
MATERIALS AND METHODS: This cohort study included 115 adult patients admitted to the ICU with SARS-CoV-2 pneumonia. Anthropometric variables and biochemical (C-reactive protein, ferritin, leukocyte, neutrophils, and fibrinogen) were measured. Multivariate logistic regression analyses were used to investigate the associations.
RESULTS: Mean age was 50.6±11.2 years, 68.7% were male. Median BMI was 30.9kg/m2. All patients had invasive mechanical ventilation. Patients with diabetes had increased risk of mortality with OR of 2.86 (CI 95% 1.1-7.4, p=0.026); among those patients who, in addition to diabetes had obesity, the risk was de 3.17 (CI 95% 1.9-10.2, p=0.038). Patients with obesity had 1.25 times greater risk of developing a severe SARS-CoV-2 infection (95% CI 1.09-1.46, p=0.025). Negative correlation was observed between BMI and the PaO2/FiO2 ratio (r=-0.023, p<0.05). Obese patients required more days of mechanical ventilation and longer hospital stay compared to non-obese patients.
CONCLUSIONS: Diabetes and obesity are risk factors for increasing severity of SARS-CoV-2 infection, and they are both associated with an increase in mortality.
Copyright © 2021 Asia Oceania Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  COVID19; Critical care; Diabetes mellitus; Obesity; SARS-CoV-2; Severe acute respiratory syndrome

Year:  2021        PMID: 34016569     DOI: 10.1016/j.orcp.2021.05.001

Source DB:  PubMed          Journal:  Obes Res Clin Pract        ISSN: 1871-403X            Impact factor:   2.288


  2 in total

1.  Association between obesity and hospital mortality in critical COVID-19: a retrospective cohort study.

Authors:  Guillaume Plourde; Emanuel Fournier-Ross; Hubert Tessier-Grenier; Louis-Antoine Mullie; Michaël Chassé; François Martin Carrier
Journal:  Int J Obes (Lond)       Date:  2021-08-25       Impact factor: 5.095

2.  Spinosin ameliorates insulin resistance by suppressing reactive oxygen species-associated inflammation.

Authors:  Chi-Yu Ge; Ling Yang; Jun-Li Zhang; Zhi-Feng Wei; Feng Feng
Journal:  Iran J Basic Med Sci       Date:  2022-07       Impact factor: 2.532

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.